A pharmaceutically acceptable salt of 3-(4-chloro-2-fluorobenzyl)-2-methyl-n (5-methyl-1h-pyrazol-3-yl)-8 (morpholinomethyl)imidazo[1,2 b]pyridazin-6-amine compound
PK201000981A0Undetermined Publication Date: 2010-12-03ELI LILLY & CO
0 Cites 0 Cited by
Patent Information
- Application Number
- PK201000981
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2010-11-27
- Publication Date
- 2010-12-03
Abstract
The present invention provides a pharmaceutically acceptable salt of 3-(4-chloro-2-fluorobenzy1)-2-methyl-N-(5-methyl-1H-pyrazol-3-y1)-8-(morpholinomethyDimidazo[1,2-b]pyridazin-6-amine compound useful in the treatment of chronic myeloproliferative disorders and various cancers, e.g., glioblastoma, breast cancer, multiple myeloma, prostate cancer, and leukemias.
Need to check novelty before this filing date? Find Prior Art